HASBROUCK HEIGHTS, N.J., June 16, 2006 (PRIMEZONE) -- U.S. MedSys Corp. (OTCBB:UMSY) (the "Company") is pleased to announce that its division Global Medical Direct ("GMD") has achieved profitability for the first time based on its unaudited May 2006 operating results. For the month, GMD generated net revenue of $494,020 versus $433,041 in April of the prior month which reflects an increase of 14% over the prior month. The gross margin and EBITDA were 31.4% and 2% respectively for the current month May versus 28% and (97.7%) for the same month of fiscal 2005. Operating expenses continue to be consistent tracking at 30.5% of net revenue.
Anthony R. Rubino, CEO, stated: "In my opinion the management team at GMD has performed above expectation. Their commitment and diligence to the overall success of UMSY has been exemplary. The division continues to consistently add new patient lives through its contracts and direct sales organization. It's been a pleasure working with them during this past year and I look forward to even more promising results in the future."
Bob Shea, Division President stated, "We are pleased with our operating results and encouraged by the additional enrollment of health plan members from some of our recently executed contracts. We anticipate strong patient enrollment throughout the fourth quarter as implementation of these contracts continues." Shea further stated, "Our patient base takes full advantage of our breadth of products and services offered, combining diabetic supplies with pharmacy medications, diabetic shoes and orthotics delivered conveniently to their homes."
Investors are encouraged to review the complete report available at www.sec.gov or at the company's website at www.usmedsyscorp.com.
About U.S. MedSys Corp.
U.S. MedSys Corp. is a medical network developer, marketing and distribution organization which provides support services and medical technology to the healthcare industry. U.S. MedSys Corp. is focusing on its core competencies in healthcare delivery, network development and marketing. The Company's purpose is to create a total platform that can be presented to healthcare providers as a means for healthcare administrators to cut costs without sacrificing quality of care to its membership. The UMSY business network consists of Global Medical Direct, a provider of sales, marketing and distribution of self-management products and services to patients with diabetes; PMC/Footcare, LLC, PMC Occular, LLC and New England Orthotic and Diabetic Shoe Company (NEODS), which has been established to manufacture and market semi-custom orthotics, diabetic shoes, insoles and orthotic braces. The company also markets its proprietary wound care program to the nursing home and wound care markets.
Safe Harbor Forward-Looking Statements:
This press release may contain "forward-looking statements" within the meaning of section 27A of the 1933 Securities Act and Section 21E of the Securities Exchange Act. Actual results could differ materially, as the result of such factors as competition in the markets for the company's products and services and the ability of the company to execute its plans. By making forward-looking statements, the company can give no assurances that the transactions described in this release will be successfully completed, and undertakes no obligation to update these statements for revisions or changes after the date of this press release.